Jenna Cohen | Senior Director and Head of Investor Relations |
Kate Haviland | Chief Executive Officer |
Philina Lee | Chief Commercial Officer |
Christy Rossi | Chief Operating Officer |
Mike Landsittel | Chief Financial Officer |
Fouad Namouni | President of Research and Development |
Becker Hewes | MD, Chief Medical Officer |
Dane Leone | Raymond James |
Ernie Rodriguez | Cowen and Co |
Brad Canino | Stifel |
Eun Yang | Jefferies |
Derek Archila | Wells Fargo |
Michael Ulz | Morgan Stanley |
Reni Benjamin | JMP Securities |
Joe Beatty | Baird |
Peter Lawson | Barclays |
David Lebowitz | Citi |
Zhi Shu | Berenberg |
Ami Fadia | Needham |
Matt Biegler | Oppenheimer |
Nicole Gabreski | Piper Sandler |
Good morning, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in listen-only-mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded.
At this time, I'd like to turn over to Jenna Cohen, Head of Investor Relations at Blueprint Medicines.